Suchergebnisse - "Fagerholm, Urban"

PubPharm (72)

31

The volume of distribution is an indicator of poor in vitro-in vivo extrapolation of clearance for acidic drugs in the rat

enthalten in: Xenobiotica | 2013

von Sohlenius-Sternbeck, A. | Fagerholm, U. | Bylund, J.

32

Commentary to Malmborg and Ploeger

enthalten in: Journal of pharmacological and toxicological methods | 2013

von Fagerholm, U.

CommentOn: J Pharmacol Toxicol Methods. 2013 May-Jun;67(3):203-13. - PMID 23280406

33

Commentary to Malmborg and Ploeger

enthalten in: Journal of pharmacological and toxicological methods | 2013

von Fagerholm, U.

34

In silico categorization of in vivo intrinsic clearance using machine learning

enthalten in: Molecular pharmaceutics | 2013

von Hsiao, Y. | Fagerholm, U. | Norinder, U.

35

In Silico Categorization of in Vivo Intrinsic Clearance Using Machine Learning

enthalten in: Molecular pharmaceutics | 2013

von Hsiao, Y. | Fagerholm, U. | Norinder, U.

36

Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation

enthalten in: The Journal of pharmacy and pharmacology | 2008

von Fagerholm, U.

37

Prediction of human pharmacokinetics—biliary and intestinal clearance and enterohepatic circulation

enthalten in: Journal of pharmacy and pharmacology | 2008

von Fagerholm, U.

38

The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans

enthalten in: Pharmaceutical research | 2008

von Fagerholm, U.

39

Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation

enthalten in: Journal of pharmacy and pharmacology | 2008

von Fagerholm, U.

40

The highly permeable blood-brain barrier : an evaluation of current opinions about brain uptake capacity

enthalten in: Drug discovery today | 2007

von Fagerholm, U.